PMGC (ELAB) Stock Price, News & Analysis

Company Overview

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Key Stats

• Today's Range: $1.91 to $2.11
• 50-Day Range: $1.67 to $14.00
• 52-Week Range: $1.62 to $309.12
• Volume: 1.62 million shs
• Average Volume: 1.44 million shs
• Market Capitalization: $2.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

PMGC Stock Analysis - MarketRank™

PMGC scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

PMGC has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

PMGC has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PMGC has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

20.38% of the float of PMGC has been sold short.

Short Interest Ratio / Days to Cover

PMGC has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PMGC has recently decreased by 43.02%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PMGC does not currently pay a dividend.

Dividend Growth

PMGC does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.78

News Sentiment

PMGC has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Multi-Sector Conglomerates companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for PMGC this week, compared to 3 articles on an average week.

Search Interest

Only 8 people have searched for ELAB on MarketBeat in the last 30 days. This is a decrease of -77% compared to the previous 30 days.

MarketBeat Follows

2 people have added PMGC to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PMGC insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.01% of the stock of PMGC is held by insiders.

Percentage Held by Institutions

22.22% of the stock of PMGC is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 5/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Multi-Sector Conglomerates
• Industry: DIVERSIFIED OPS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ELAB
• Previous Symbol: NASDAQ:ELAB
• CIK: 1840563
• Web: elevaiskincare.com
• Phone: 866-794-4940
• Fax: N/A
• Employees: 18
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($400.97)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.75 million
• Net Margins: N/A
• Pretax Margin: -1,313.56%
• Return on Equity: -92.90%
• Return on Assets: -67.56%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 1.74
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: $590.08 thousand
• Price / Sales: 4.09
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $93.33 per share
• Price / Book: 0.02

Miscellaneous

• Outstanding Shares: 1,159,000
• Free Float: 1,159,000
• Market Cap: $2.41 million
• Optionable: N/A
• Beta: -0.27